Dublin, April 13, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Next Generation Sequencing Market Assessment & Forecast: 2017 - 2021" report to their offering. Next generation sequencing (NGS) technology market is constantly evolving due to continuous technology upgrades. At least five companies are currently developing novel NGS technology that is anticipated to commercialize during the forecast period. Although currently the market is dominated by Illumina, various other companies are investing in development of novel methods for efficient and cost effective sequencing. Genapsys is currently developing Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology, a portable sequencer targeted for research and diagnostic laboratory purposes. The company opened early access registration in 2014, yet commercial launch has not been announced officially. Agilent Technologies invested US$ 80 million in LaserGen for development and commercialization of the proprietary lightning terminators technology. Although Nabsys had closed operations in 2015 after 10 years of struggle in development of its next generation sequencing technology, the company was re-launched as Nabsys 2.0 in 2016. The company also received US$ 42 million in funding from a Chinese company Zixin Pharma. Majority of the sequencing technologies in pipeline are nanopore based. The market has witnessed series of acquisitions and strategic agreements in the recent past and become more competitive. It is also anticipated that the market would consolidate, remain dominated by the North America region. However, rapid growth is anticipated in Asia Pacific region due to increased adoption of the technology in varied fields. In 2016, China announced the opening of China National GeneBank (CNGB). The bank consists of biorepository, bioinformatics data center and living biobank, and a digitalization platform and synthesis and editing platform. Similar gene banks in Japan, South Korea, India and others are contributing immensely to genetic research in agriculture. Chinese FDA granted Class I status for Vela Diagnostics' Sentosa SX101 instrument for clinical use. In 2015, KEW Group Inc. and Denka Co., Ltd. announced collaborative agreement for evaluation of KEW's CancerPlex NGS Testing in Japanese cancer patients. Government investment in genome sequencing projects and widespread integration of NGS technology with other research programs are driving the NGS market. Increasing efforts by regulatory agencies in keeping pace with rapid technology developments and proactive approach in approval of NGS based tests in disease diagnosis has encouraged companies and investment firms to consider NGS technology as one of the most lucrative options. Key players mentioned in the report include Illumina, Inc., Thermo Fisher Scientific, Inc., Oxford Nanopore, Pacific Biosciences, Qiagen N.V., Roche Sequencing, Stratos Genomics, GnuBio and others. Key Topics Covered: Chapter 1 Preface Chapter 2 Précis Chapter 3 Market Dynamics 3.1 Market Drivers 3.1.1 Government funding and initiatives towards gene banking to boost adoption of next generation sequencing technology 3.1.2 Increasing scope of application of next generation sequencing expanding end-user profile 3.1.3 Increasing regulatory approvals for NGS based tests encouraging companies to invest in test development 3.1.4 Next generation sequencing service providers to drive growth in spite of lack of knowledge and expertise 3.2 Market Restraints 3.2.1 Reimbursement challenges for NGS based tests 3.2.2 High cost of set-up for next generation sequencing systems 3.3 Market Opportunities 3.3.1 Opportunities in reagents and consumables segment 3.3.2 Companies engaging in strategic agreements for sharing clientele and developing NGS technology 3.4 U.S. FDA guidelines for next generation sequencing tests 3.5 Recent FDA approvals Chapter 4 Next Generation Sequencing - Global Market Assessment by Key Players, Forecast: 2017 to 2021 4.1 Introduction 4.2 Illumina, Inc. Next Generation Sequencing Market Assessment, by Product Type, US$ Million (2015 - 2021) 4.3 Thermo Fisher Scientific, Inc. Next Generation Sequencing Market Assessment, by Product Type, US$ Million (2015 - 2021) 4.4 Roche Sequencing Next Generation Sequencing Market Assessment, by Product Type, US$ Million (2015 - 2021) 4.5 Pacific Biosciences of California, Inc. Next Generation Sequencing Market Assessment, by Product Type, US$ Million (2015 - 2021) 4.6 Qiagen N.V. Next Generation Sequencing Market Assessment, by Product Type, US$ Million (2015 - 2021) 4.7 Oxford Nanopore Technologies Next Generation Sequencing Market Assessment, by Product Type, US$ Million (2015 - 2021) 4.8 Other Companies Next Generation Sequencing Market Assessment, by Product Type, US$ Million (2015 - 2021) Chapter 5 Next Generation Sequencing Services - Global Market Assessment by Applications, Forecast: 2017 to 2021 5.1 Introduction 5.2 Next Generation Sequencing Services Market in Diagnosis, 2015 - 2021 (US$ Million) 5.3 Next Generation Sequencing Services Market in Genome Sequencing, 2015 - 2021 (US$ Million) 5.4 Next Generation Sequencing Services Market in Biopharmaceutical Research, 2015 - 2021 (US$ Million) 5.5 Next Generation Sequencing Services Market in Food and Agriculture, 2015 - 2021 (US$ Million) 5.6 Next Generation Sequencing Services Market in Other Applications, 2015 - 2021 (US$ Million) Chapter 6 Next Generation Sequencing Instruments, Reagents and Consumables - Global Market Assessment by End-Users, Forecast: 2017 to 2021 6.1 Introduction 6.2 Next Generation Sequencing Instruments, Reagents and Consumables Market at Universities, Academia and Research Institutes, 2015 - 2021 (US$ Million) 6.3 Next Generation Sequencing Instruments, Reagents and Consumables Market at Service Providers, 2015 - 2021 (US$ Million) 6.4 Next Generation Sequencing Instruments, Reagents and Consumables Market at Other End-Users, 2015 - 2021 (US$ Million) Chapter 7 Next Generation Sequencing - Global Market Assessment by Geography, Forecast: 2017 to 2021 Chapter 8 Key Player Analysis: Global Next Generation Sequencing Market, 2016 8.1 Global Next Generation Sequencing Market: Recent Developments 2014-2016 8.1.1 Mergers and Acquisitions 8.1.2 Strategic Agreement 8.1.3 Product Approvals and Launch Chapter 9 Epilogue For more information about this report visit http://www.researchandmarkets.com/research/gx...lobal_next
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Molecular Diagnostics
